A detailed history of Iag Wealth Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Iag Wealth Partners, LLC holds 335 shares of AMGN stock, worth $98,667. This represents 0.02% of its overall portfolio holdings.

Number of Shares
335
Previous 358 6.42%
Holding current value
$98,667
Previous $111,000 3.6%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$309.38 - $337.38 $7,115 - $7,759
-23 Reduced 6.42%
335 $107,000
Q2 2024

Jul 16, 2024

BUY
$262.75 - $319.31 $61,483 - $74,718
234 Added 188.71%
358 $111,000
Q2 2023

Aug 10, 2023

BUY
$214.27 - $253.37 $22,284 - $26,350
104 Added 520.0%
124 $27,000
Q1 2023

Apr 25, 2023

SELL
$225.79 - $275.2 $47,641 - $58,067
-211 Reduced 91.34%
20 $4,000
Q4 2022

Feb 08, 2023

SELL
$229.03 - $291.01 $4,580 - $5,820
-20 Reduced 7.97%
231 $60,000
Q3 2022

Oct 26, 2022

BUY
$224.46 - $253.15 $448 - $506
2 Added 0.8%
251 $57,000
Q2 2022

Aug 03, 2022

SELL
$230.71 - $256.74 $1,153 - $1,283
-5 Reduced 1.97%
249 $61,000
Q1 2022

May 04, 2022

BUY
$219.27 - $242.57 $4,823 - $5,336
22 Added 9.48%
254 $62,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $198 - $227
1 Added 0.43%
232 $52,000
Q3 2021

Nov 04, 2021

BUY
$212.27 - $248.7 $424 - $497
2 Added 0.87%
231 $49,000
Q2 2021

Aug 04, 2021

BUY
$233.58 - $259.14 $467 - $518
2 Added 0.88%
229 $56,000
Q1 2021

Apr 29, 2021

BUY
$221.91 - $258.6 $44,382 - $51,720
200 Added 740.74%
227 $57,000
Q3 2020

Feb 11, 2021

SELL
$234.65 - $260.95 $2,346 - $2,609
-10 Reduced 27.03%
27 $7,000
Q4 2019

Feb 11, 2021

BUY
$189.21 - $243.2 $7,000 - $8,998
37 New
37 $9,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Iag Wealth Partners, LLC Portfolio

Follow Iag Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iag Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iag Wealth Partners, LLC with notifications on news.